With increasing competition in the skincare market, FDA (Food and Drug Administration) filing is essential for brands entering the U.S. However, challenges like ingredient compliance, labeling, and manufacturing standards can lead to recalls or legal risks. As consumer expectations rise, FDA regulations are becoming stricter. How can skincare brands ensure a smooth filing process? This article highlights key considerations to help brands achieve compliance and succeed in the U.S. market!
Basic Requirements for FDA Filing
FDA filing (FDA Registration) refers to the process where manufacturers or distributors of cosmetics, OTC drugs, or medical devices submit product and facility information to the U.S. Food and Drug Administration (FDA). Filing does not mean FDA approval but ensures that the product is within the regulatory system for market monitoring and safety management.
Scope of FDA Filing
(1) Cosmetics
Applicable Products: Skincare, makeup, personal care products, perfumes, etc.
Filing Requirements:
Under the Modernization of Cosmetics Regulation Act (MoCRA), all cosmetics sold in the U.S. must have facility registration and product listing.
The product must be safe for use and free from prohibited ingredients (e.g., certain mercury compounds and restricted color additives).
Labeling compliance is required, including ingredient lists, usage instructions, and manufacturer details.
(2) OTC Drugs (Over-the-Counter Drugs)
Applicable Products: Skincare products containing active drug ingredients, such as sunscreens, acne treatments, antiperspirants, and antibacterial hand sanitizers.
Filing Requirements:
Products must comply with FDA OTC Monograph regulations or apply for NDA (New Drug Application).
Manufacturing facilities must follow Good Manufacturing Practices (GMP, 21 CFR Part 210 & 211) and be registered with the FDA.
Labeling must follow drug regulations, including a Drug Facts panel outlining active ingredients, usage instructions, and warnings.
(3) Medical Devices (For Certain Skincare Products)
Applicable Products: Skincare tools such as sonic facial cleansers, laser beauty devices, and microneedle rollers.
Filing Requirements:
Depending on the device classification (Class I, II, or III), a 510(k) clearance or PMA (Premarket Approval) may be required.
Manufacturers and importers must complete FDA establishment registration and device listing.
FDA Filing Process and Steps
For skincare products, OTC drugs, or beauty devices to enter the U.S. market successfully, brands must complete the FDA filing process and comply with regulatory requirements. Below are the key steps:
1. Determine Product Classification
Different product categories fall under different FDA regulations. The first step is to identify which category your product belongs to:
✔ Cosmetics: Includes skincare, makeup, personal care products, etc., regulated under MoCRA (Modernization of Cosmetics Regulation Act).
✔ OTC Drugs (Over-the-Counter Drugs): Includes skincare products with active drug ingredients (e.g., sunscreens, acne treatments) and must comply with OTC Monograph or require an NDA (New Drug Application).
✔ Medical Devices: Includes beauty devices such as microneedling rollers and facial therapy devices, which require FDA Device Registration.
2. Facility Registration
This step applies to cosmetic, OTC drug, and medical device manufacturers:
Cosmetics: Under MoCRA, all cosmetic manufacturers must register their facilities with the FDA and renew registration every two years.
OTC Drugs: Manufacturers must comply with GMP (Good Manufacturing Practices, 21 CFR Part 210 & 211) and register their facilities.
Medical Devices: Manufacturers must complete FDA Establishment Registration and submit a Device Listing.
Foreign manufacturers must appoint a U.S. Agent to communicate with the FDA.
3. Product Listing
(1) Cosmetic Product Listing (MoCRA)
Submit product name, brand, ingredient list, and intended use.
Each product must be registered in the Cosmetic Product Facility Registration System (CPFRS).
(2) OTC Drug Product Listing
Ensure compliance with OTC Monograph or apply for NDA (New Drug Application).
Submit NDC (National Drug Code) registration.
Register the product in FDA’s Drug Registration and Listing System (DRLS).
(3) Medical Device Listing
Determine device classification (Class I, II, or III).
Some devices require 510(k) clearance or PMA (Premarket Approval).
Register the device in FDA’s Device Registration and Listing system.
4. Labeling Compliance
All products must meet FDA labeling requirements, including:
✔ Ingredient list (INCI format for cosmetics).
✔ Manufacturer or importer details.
✔ Net content (weight or volume).
✔ Product usage instructions and warnings.
✔ OTC drugs must use the “Drug Facts” format, specifying active ingredients, indications, and side effects.
5. Import & Market Surveillance
The FDA does not pre-approve cosmetics, but customs may inspect shipments to verify compliance.
OTC drugs and medical devices require stricter scrutiny before entering the market.
If inspected, manufacturers must provide compliance documents and lab test reports.
The FDA conducts post-market surveillance, and non-compliance may lead to warning letters, recalls, or sales bans.
6. Ongoing Compliance & Updates
MoCRA requires cosmetic facility registration to be updated every two years, and product listings should be kept current.
OTC drug and medical device facility registrations must be renewed annually.
If product formulations, labels, or manufacturing details change, an updated filing must be submitted to the FDA.
Key Considerations for FDA Filing
When filing with the FDA, companies must pay close attention to the following key points to ensure successful market entry and compliance with regulations:
1. Determine Product Classification & Applicable Regulations
Different product categories fall under different FDA regulations. Before filing, it is crucial to correctly classify your product:
✔ Cosmetics: Must comply with MoCRA (Modernization of Cosmetics Regulation Act), requiring facility registration and product listing.
✔ OTC Drugs: Products containing active drug ingredients (e.g., sunscreens, acne treatments) must follow the OTC Monograph or apply for NDA (New Drug Application).
✔ Medical Devices: Beauty devices (e.g., microcurrent devices, laser therapy) require FDA Device Registration and may need 510(k) clearance or PMA approval.
📌 Incorrect classification can result in an invalid filing or regulatory risks!
2. Filing Information Must Be Accurate & Complete
FDA filing requires the submission of:
✔ Facility registration details (for manufacturers, packagers, or private labelers).
✔ Product name and full ingredient list (INCI format for cosmetics).
✔ Labeling and usage instructions (OTC drugs require a “Drug Facts” panel).
✔ Foreign manufacturers must appoint a U.S. Agent to communicate with the FDA.
📌 Incorrect or incomplete filing information may lead to rejection, shipment detention, or compliance issues!
3. Labeling Must Meet FDA Compliance Standards
Product labels must adhere to FDA’s mandatory labeling requirements, including:
✔ Cosmetics cannot make drug-like claims (e.g., “treats acne,” “heals skin”).
✔ OTC drugs must include a “Drug Facts” panel, listing active ingredients, usage, and warnings.
✔ Labels must clearly display ingredients, net content, and manufacturer details.
✔ All information must be in English, with optional translations.
📌 Non-compliant labeling may result in FDA shipment refusal or product recalls!
4. Not Making Medicinal Claims
Cosmetics can only claim to enhance appearance, cleanse, or moisturize.
✔ Acceptable examples: Moisturizing, brightening skin tone, improving skin texture
❌ Unacceptable examples: Treating acne, anti-inflammatory, curing eczema
OTC drugs (Over-the-Counter Drugs) can claim to treat specific skin conditions but must comply with the OTC Monograph or obtain NDA (New Drug Application) approval. The label must also include a Drug Facts panel.
📌 If a cosmetic product makes medicinal claims, the FDA may classify it as a drug, subjecting it to stricter regulations, potential import refusal, or sales restrictions!
FDA Filing Requirements for Specialty Skincare Products
Specialty skincare products, such as anti-aging creams, acne treatments, sunscreens, and skin-brightening products, may fall under different FDA regulatory categories depending on their ingredients and claims. Here’s what you need to know when filing:
1. Determine the Correct Classification
FDA classifies skincare products into two categories:
✔ Cosmetics: If the product is intended only for cleansing, beautifying, or enhancing appearance, it is regulated as a cosmetic under the Modernization of Cosmetics Regulation Act (MoCRA).
✔ OTC Drugs: If the product makes medical claims (e.g., “treats acne,” “prevents sunburn”), it is considered an OTC drug and must follow OTC Monograph or obtain NDA (New Drug Application) approval.
📌 Misclassification can lead to compliance issues, import refusal, or product recalls!
2. Common Specialty Skincare Product Categories & FDA Requirements
Anti-aging products (e.g., retinol creams, peptide serums)
Cosmetic: Non-therapeutic claims (e.g., “improves appearance of wrinkles”).
OTC drug: Therapeutic claims (e.g., “permanently reduces wrinkles”).
Acne treatments (e.g., salicylic acid, benzoyl peroxide)
OTC drug: Must comply with OTC Monograph or seek approval.
Sunscreens (SPF-containing)
OTC drug: Require “Drug Facts” panel and FDA sunscreen rules.
Skin-brightening products (e.g., hydroquinone, arbutin, vitamin C)
OTC drug: Whitening claims. Hydroquinone ≤2% = cosmetic; >2% = drug approval.
Whitening creams (“skin whitening” claims)
Mostly drugs: High-risk ingredients (e.g., high-concentration hydroquinone) require approval.
3. Filing Requirements Based on Product Type
For Cosmetics:
Facility Registration: Required under MoCRA for U.S. and foreign manufacturers.
Product Listing: Full ingredient disclosure in INCI format is mandatory.
Labeling Compliance: Must avoid drug claims and follow FDA cosmetic labeling rules.
For OTC Drugs:
Facility Registration & Drug Listing: Must be filed under FDA’s Drug Registration and Listing System (DRLS).
Drug Facts Panel: Label must include active ingredients, uses, warnings, and directions.
Compliance with OTC Monograph: Must follow FDA’s specific guidelines for each drug type.
GMP (Good Manufacturing Practices): Must be produced in FDA-registered and GMP-compliant facilities.
📌 OTC drug compliance is stricter, requiring more regulatory steps before market entry!
4. Additional Considerations for FDA Compliance
✔ Ingredient Restrictions: Certain ingredients (e.g., mercury compounds, high concentrations of hydroquinone) are prohibited or restricted.
✔ No Misleading Claims: Avoid statements like “cures eczema” or “permanently removes wrinkles” unless approved as a drug.
✔ Import & Market Entry: FDA may inspect products at U.S. customs for compliance.
✔ Post-Market Surveillance: The FDA can issue warning letters, request recalls, or conduct audits if non-compliance issues arise.
Post-Filing Product Tracking and Regulation
Once a product is filed with the FDA, ongoing compliance and monitoring are essential. Here are the key aspects of post-filing tracking and regulation:
Adverse Event Reporting: Manufacturers must monitor for any adverse reactions or product-related issues and promptly report significant events to the FDA. This continuous reporting helps ensure consumer safety.
Post-Market Surveillance: The FDA actively monitors products on the market through routine inspections, consumer feedback, and market surveillance programs. This process helps identify non-compliance or safety concerns early on.
Facility and Product Updates: Companies are required to update their facility registrations and product listings whenever there are changes in formulation, labeling, or manufacturing processes. Timely updates ensure that the FDA has current information on all products.
Compliance Inspections: Both domestic and foreign manufacturing facilities may be subject to periodic FDA inspections to verify adherence to good manufacturing practices (GMP) and other regulatory requirements. These inspections help maintain product quality and safety.
Recall and Enforcement Actions: If a product is found to be non-compliant or poses a risk to consumers, the FDA can issue warning letters, mandate product recalls, or take other enforcement actions to remove the product from the market.
Common Questions and Mistakes in FDA Registration
Understanding and avoiding common pitfalls during FDA registration can help ensure a smooth process and maintain long-term compliance. Here’s an overview of the most frequent questions and errors:
Common Questions
FDA Registration vs. FDA Approval: Many companies mistakenly believe that registering with the FDA means the product has been approved. In reality, registration is simply the submission of product and facility information—it does not signify an endorsement of safety or efficacy.
Product Classification: Determining whether a product is classified as a cosmetic, OTC drug, or medical device is crucial. For example, products intended solely for beautifying or cleansing are cosmetics, while those with therapeutic claims (e.g., treating acne) may be regulated as OTC drugs.
Scope of Registration: Not all products require FDA registration. Typically, products sold in the U.S. such as cosmetics, OTC drugs, and certain medical devices must be registered according to specific regulatory guidelines.
Update Frequency: How often should registration information be updated? Generally, cosmetic facility registrations under MoCRA are updated every two years, while OTC drugs and medical devices may require annual updates or immediate updates upon any changes in formulation, labeling, or manufacturing.
Common Mistakes
Incorrect Product Classification: Misclassifying a product—such as labeling a product with drug-like claims as a cosmetic—can lead to stricter regulatory requirements, potential import issues, or even product recalls.
Incomplete or Inaccurate Registration Information:
Submitting missing, incorrect, or improperly formatted data (e.g., failing to follow INCI format for ingredient lists) may result in a rejected registration or issues during inspections.
Non-Compliant Labeling:
Labels must adhere to FDA guidelines. Common errors include making unapproved medicinal claims, missing required information (such as ingredient lists, net contents, or manufacturer details), or not providing an English version of the label.
Failure to Update Registration:
Not updating registration details when there are changes in the product formulation, labeling, or manufacturing processes can lead to non-compliance and affect market access.
Supply Chain Non-Compliance:
Partnering with manufacturers or suppliers that are not FDA-registered or do not comply with GMP standards can jeopardize product quality and result in enforcement actions.
Key Recommendations
Verify all submitted information: Ensure that all data is accurate, complete, and compliant with FDA requirements.
Implement regular reviews: Establish internal procedures to periodically review and update registration and manufacturing details.
Follow labeling guidelines closely: Adhere strictly to FDA labeling standards, avoiding any unapproved claims.
Choose compliant partners: Work exclusively with suppliers and manufacturers who meet FDA registration and GMP standards.
In summary, proper FDA registration is essential for ensuring your skincare products can successfully and safely enter the U.S. market. By carefully following the guidelines for product classification, facility registration, product listing, and labeling compliance, companies can minimize regulatory risks and maintain consumer trust!
If you have any further questions or need additional assistance, please feel free to contact us. Our company boasts many years of experience in the skincare industry and has successfully helped global brand owners overcome challenges in sourcing skincare products from China. We’re here to support your journey towards regulatory compliance and market success!
